The level of AURKA and pAURKA in the over-expressing cells was significantly higher than in other melanoma cell lines previously characterised as having an ATM checkpoint defect, although it was comparable to that in two melanoma cell lines with inactivating mutations in PP6C, a negative regulator of AURKA16,23 (Fig. 1B). The gene discussed is PPP6C; the disease is melanoma.